Læknablaðið - 15.03.1994, Blaðsíða 36

122
LÆKNABLAÐIÐ
calculated for every stage and multivariate analysis
used to find independent prognostic factors.
Age adjusted incidence for carcinoma of the
renal pelvis was 1,1/105 males and 0,4/105
females per year. Comparable figures for ureteral
carcinoma were 0,4/105 males and 0,1/105 females,
respectively. Most of the patients presented with
hematuria and abdominal or flank pain. Of 54
staged patients 28 were stage I-III (54%) and 24
stage IV (46%). Metastasis were found in 22%
of the patients, most often in lymph nodes and
lungs. Crude five year survival was 44% for the
group as a whole, 88% for stage I and 21% for
stage IV. Year of diagnosis was not an independent
prognostic factor.
Carcinomas of the ureter and renal pelvis are
uncommon. Incidence in Iceland is relatively low
and the clinical presentation similar to neighboring
countries. Survival is comparable, in particular for
patients with metastasis, but it has not changed for
the last two decades.
ÞAKKIR
Yfirlæknar á skurð- og þvagfæraskurðdeild
Borgarspítala, Landakots og FSA fá sérstakar
þakkir fyrir veitta aðstoð. Einnig er Helga
Sigvaldasyni verkfræðingi, Hrafni Tulinius
og öðrum starfsmönnum Krabbameinsskrár
Krabbameinsfélags íslands þakkað sérstaklega
fyrir þeirra framlag.
Vísindasjóður Landspítala og Rannsóknastofu
Háskólans, Minningarsjóður Bergþóru
Magnúsdóttur og Jakobs J. Bjarnasonar og
Vísindasjóður Krabbameinsfélags Islands
styrktu rannsóknina.
HEIMILDIR
1. Tulinius H, Ragnarsson J. Nýgengi krabbameina á
íslandi 1955-1984. Heilbrigðisskýrslur, Reykjavík:
Krabbameinsfélagið og landlæknisembættið, 1987.
Fylgirit nr. 3: 6.
2. Hvidt V, Feldt-Rassmussen K. Primary tumours in
the renal pelvis and ureter with particular attention
to the diagnostic problems. Acta Chir Scand 1973;
Suppl 433: 91-101.
3. Wagle DG. Moore RH. Murphy GP. Primary
carcinoma of the renal pelvis. Cancer 1974; 33: 1642-
8.
4. Guinan P, Vogelzang NJ, Randazzo R. Renal pelvic
cancer: A review of 611 patients treated in Ulinois
1975-1985. Urology 1992; 40: 393-9.
5. Grabstald H, Withmore WF. Melmamed MR. Renal
pelvic tumors. JAMA 1971: 218: 845-54.
6. Rubenstein MA. Walz BJ, Bucy JG. Transitional cell
carcinoma of the kidney: 25 years experiencc. J Urol
1978; 119: 594-7.
7. Nocks B, Heney NH, Daley JJ, et al. Transitional cell
carcinoma of the renal pelvis. Urology 1982; 19: 472-
7.
8. Huben RP, Mounzer AM, Murphy GP. Tumor grade
and stage as prognostic variables in upper tract
urothelial tumors. Cancer 1988; 62: 2016-20.
9. Babaian RJ. Johnson DE. Primary carcinoma of the
ureter. J Urol 1980; 123: 357-9.
10. Guðbjartsson T, Einarsson GV. Magnússon J.
Nýrnafrumukrabbamein á Islandi 1971-1990: Nýgengi
og sjúkdómseinkenni. - Klínísk rannsókn á 408
tilfellum-. Læknablaðið 1994; 80: 13-9.
11. Catalona WJ. Bladder cancer. In: Walsh PC. Retik
AB. eds. Campel’s urology, 6. ed. Philadelphia: WB
Saunders Comp. 1992: 1094-5.
12. Mostofi FK, Sobing LH, Torloni H, et al.
International histological classification of tumours no.
10. Histological typing of urinary bladder tumours.
Geneva: WHO, 1973.
13. Kaplan EL, Meier P. Nonparametric estimation from
incomplete observations. J Am Stat Ass 1958; 53:
457-81.
14. Cox DR. Regression models and life tables. J Roy
Stat Soc 1972; B34: 187-220.
15. Taron RE. Test for trend in lifetable analysis.
Biometrika 1975; 62: 679-82.
16. Parkin DM. Muir CS, Whelan SL. et al. Cancer
incidcnce in five continents, Vol. VI. Intemational
agency for research on cancer. Lyon: WHO, 1992.
17. Tulinius H. Storm HH. Pukkala E. et al. Cancer in
the Nordic Countries, 1981-86. A joint publication of
the live Nordic cancer registries, Acta Path Micr Im
Scand 1992; 100/Suppl. 31: 95-6.
18. Nprgaard N. Mcllemgaard A. Olsen JH, ct al.
Nyrepelvis- og uretertumorer i Danmark 1943-1986.
Kræftstatistik nr. 28. Ugeskr Læg 1991; 153: 778-82.
19. Fraley E. Cancer of the renal pelvis. In: Skinner
DG. deKernion JB, eds. Genitourinary cancer.
Philadelphia: WB Saunders, 1978: 134.
20. McDonald MW, Zincke H. Urothelial tumors of the
upper urinary tract. Chapter 1. Genitourinary cancer
management. Philadelphia: Lea and Fabinger, 1987:
1-32.
21. McCredie M. Stewart JH. Ford JM. Analgesics and
tobacco as risk factors for cancer of the ureter and
renal pelvis. J Urol 1983: 130: 281.
22. Petkovic SD. Epidemiology and treatment of renal
pelvic and ureteral tumors. J Urol 1975; 114: 858-65.
23. Randovanovic Z. Krajinovic S. Jankovic S, et al.
Family history of cancer among cases of upper
urothelial tumours in a Balkan nephropathy area. J.
Cancer Res Clin Oncol 1985; 110: 181-5.'
24. Anderström C, Johansson SL, Pettersson S, et al.
Carcinoma of the ureter: A clinicopathologic study
of 49 cases. J Urol 1989; 142: 280-3.
25. Bloom NA. Vidone RA. Lytton B. Primary carcinoma
of thc ureter: a report of 102 new cases. J Urol 1970;
103: 590-8.
26. Oldbring J. Glifberg I, Mikulowski P, et al.
Carcinoma of the renal pelvis and ureter following
bladder carcinoma: Frcquency risk factors and
clinicopathological findings. J Urol 1989; 141: 1311-
3.
27. Guðbjartsson T, Einarsson GV, Magnússon J.
Nýrnafrumukrabbamein á íslandi 1971-1990: Stigun
og lífshorfur. - Klínísk rannsókn á 408 tilfellum-.
Læknablaðið 1994; 80: 49-56.
28. Catalona WJ. Urothelial tumors of the renal pelvis
and ureter. In: Walsh PC. Retik AB, eds. Campel’s
urology 6. ed. Philadelphia: WB Saunders, 1992:
1137-58.